Bedaquiline overdose: A case report
Bedaquiline is a new anti-tuberculosis medication used for treatment of drug resistant infections.

A 21 year old HIV-negative man who received treatment with bedaquiline. Due to error, dosage received comprised 4 pills of 100 mg every second day in the 60 days following the first two weeks of 4 pills of 100 mg every day. On detection, treatment was continued as per standard dosing of 200 mg given three times per week, with enhanced monitoring of ECG and liver function. The man was asymptomatic, with no signs of jaundice, abdominal pain, or abnormal heart rhythm. Toxic effects at this dosage were therefore not observed.

Read more:
A●●●z I●●●l and 12 others like this2 shares